ViaCyte proposes stem cell implant to address type 1 diabetes

05/31/2011 | Los Angeles Times (tiered subscription model)

San Diego-based ViaCyte has proposed implanting a pouch filled with pancreatic cells under the skin to help reduce insulin dependence among patients with type 1 diabetes. The firm tested the procedure to treat diabetes in mice and hopes to initiate human trials in patients by 2013.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC